CompletedNot applicableNCT02498301

Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD

Studying Reactive arthritis

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
Principal Investigator: Ramiro Gutierrez, MD
Naval Medical Research Center
Intervention: Rifaximin(drug)
Enrollment: 449 enrolled
Eligibility: 18 years · All sexes
Timeline: 2015 – 2019

Study locations (6)

Naval Medical Center San Diego, San Diego, California, United States
Tripler Army Medical Center/Schofield Barracks, Honolulu, Hawaii, United States
Naval Hospital Camp Lejeune, Marine Corps Base Camp Lejeune, North Carolina, United States
San Antonio Military Medical Center, San Antonio, Texas, United States
Madigan Army Medical Center, Tacoma, Washington, United States
British Army Training Unit Kenya, Nanyuki, Kenya

Collaborators

Naval Medical Research Center · Ministry of Defence, United Kingdom

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02498301 on ClinicalTrials.gov

Other trials for Reactive arthritis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT04751396
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center

See all trials for Reactive arthritis →

← Back to all trials